PH29985A - Substituted quinolines and medicinal use thereof - Google Patents

Substituted quinolines and medicinal use thereof

Info

Publication number
PH29985A
PH29985A PH37861A PH37861A PH29985A PH 29985 A PH29985 A PH 29985A PH 37861 A PH37861 A PH 37861A PH 37861 A PH37861 A PH 37861A PH 29985 A PH29985 A PH 29985A
Authority
PH
Philippines
Prior art keywords
stands
pct
carboxy
bond
stand
Prior art date
Application number
PH37861A
Other languages
English (en)
Inventor
Ian Ahnfelt-Ronne
Erik Torngaard Hansen
Dorte Kirstein
Ole Bent Tvaermose Nielsen
Schneur Rachlin
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of PH29985A publication Critical patent/PH29985A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
PH37861A 1987-12-01 1988-11-25 Substituted quinolines and medicinal use thereof PH29985A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878728051A GB8728051D0 (en) 1987-12-01 1987-12-01 Chemical compounds

Publications (1)

Publication Number Publication Date
PH29985A true PH29985A (en) 1996-10-29

Family

ID=10627789

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37861A PH29985A (en) 1987-12-01 1988-11-25 Substituted quinolines and medicinal use thereof

Country Status (16)

Country Link
US (1) US5110819A (fr)
EP (1) EP0420844B1 (fr)
JP (1) JPH03501477A (fr)
KR (1) KR900700454A (fr)
AT (1) ATE110364T1 (fr)
CA (1) CA1336602C (fr)
DE (1) DE3851232T2 (fr)
ES (1) ES2011919A6 (fr)
GB (1) GB8728051D0 (fr)
GR (1) GR1000422B (fr)
IE (1) IE64473B1 (fr)
NZ (1) NZ227003A (fr)
PH (1) PH29985A (fr)
PT (1) PT89118B (fr)
WO (1) WO1989005294A1 (fr)
ZA (1) ZA888763B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
GB8919504D0 (en) * 1989-08-29 1989-10-11 Leo Pharm Prod Ltd Chemical compounds
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
US5281593A (en) * 1990-07-31 1994-01-25 Lilly Industries Limited Certain indole derivatives useful as leukotriene antagonists
AU654140B2 (en) * 1990-07-31 1994-10-27 Lilly Industries Limited N-benzyl indoles, processes for their preparation or pharmaceutical compositions containing them
WO1994014797A1 (fr) * 1992-12-23 1994-07-07 Smithkline Beecham Corporation Composes de quinoline utilises dans le traitement de maladies associees aux leucotrienes
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
GB9414590D0 (en) * 1994-07-20 1994-09-07 Leo Pharm Prod Ltd Chemical compounds
ES2103180B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Fenilacetamidas con accion antagonista de los leucotrienos.
US5602110A (en) * 1994-08-31 1997-02-11 Case Western Reserve University Method and composition for treating cystic fibrosis
EP0725063A1 (fr) * 1995-02-01 1996-08-07 Ciba-Geigy Ag Dérivés de la quinoline
ES2117551B1 (es) * 1995-12-29 1999-04-01 Menarini Lab Quinolinas naftalenicas con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de las mismas.
US5756518A (en) * 1996-04-02 1998-05-26 Kowa Co., Ltd. Phenylene derivatives
US6376671B1 (en) 1997-06-17 2002-04-23 Kaken Pharmaceutical Co., Ltd. 2-sulfamoylbenzoic acid derivatives
WO1998057935A1 (fr) * 1997-06-17 1998-12-23 Kaken Pharmaceutical Co., Ltd. Derives d'acide 2-sulfamoylbenzoique
JP2004137284A (ja) * 1997-06-17 2004-05-13 Kaken Pharmaceut Co Ltd ２−スルファモイル安息香酸誘導体
EP0905133B1 (fr) * 1997-09-26 2002-04-24 Kowa Co. Ltd. Dérivés de tétrazole en tant qu'antagonistes de LTD4 et de H1
CZ20013834A3 (cs) 1999-04-28 2002-04-17 Aventis Pharma Deutschland Gmbh Deriváty kyselin se třemi arylovými zbytky jako ligandy receptorů PPAR a farmaceutické prostředky, které je obsahují
KR20020081424A (ko) * 2000-03-09 2002-10-26 아벤티스 파마 도이칠란트 게엠베하 Ｐｐａｒ 매개인자의 치료학적 용도
TW200418825A (en) 2002-12-16 2004-10-01 Hoffmann La Roche Novel (R)-and (S) enantiomers of thiophene hydroxamic acid derivatives
JP4875978B2 (ja) * 2004-03-15 2012-02-15 武田薬品工業株式会社 アミノフェニルプロパン酸誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
ES8801209A1 (es) * 1985-06-18 1988-01-01 Merck Frosst Canada Inc Un procedimiento para la preparacion de quinolinas 2-sustituidas.
EP0219307A3 (fr) * 1985-10-16 1987-10-14 Merck Frosst Canada Inc. Quinoléines 2-substituées
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
US4904786A (en) * 1986-01-27 1990-02-27 American Home Products Corporation Quinoline compounds as antiallergic and antiinflammatory agents
GB2185741B (en) * 1986-01-27 1989-10-25 American Home Prod Heterocyclic sulphonamides
IE59889B1 (en) * 1986-02-14 1994-04-20 Merck Frosst Canada Inc 2-substituted quinoline dioic acids
EP0271287A3 (fr) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Acides quinoléine dicarboxyliques et leurs amides
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
KR900700454A (ko) 1990-08-13
NZ227003A (en) 1991-11-26
ZA888763B (en) 1989-07-26
PT89118A (pt) 1988-12-01
IE883419L (en) 1989-06-01
US5110819A (en) 1992-05-05
EP0420844A1 (fr) 1991-04-10
WO1989005294A1 (fr) 1989-06-15
GR1000422B (el) 1992-06-30
JPH03501477A (ja) 1991-04-04
IE64473B1 (en) 1995-08-09
ATE110364T1 (de) 1994-09-15
GB8728051D0 (en) 1988-01-06
CA1336602C (fr) 1995-08-08
ES2011919A6 (es) 1990-02-16
EP0420844B1 (fr) 1994-08-24
DE3851232T2 (de) 1995-02-02
DE3851232D1 (de) 1994-09-29
PT89118B (pt) 1993-04-30

Similar Documents

Publication Publication Date Title
PH29985A (en) Substituted quinolines and medicinal use thereof
DE3854454D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung.
MA26697A1 (fr) Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant
DE69512930T2 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
EA199900242A1 (ru) Аралкил- и аралкилиден-гетероциклические лактамы и имиды
TR199900046T2 (xx) Se�ici siklooksijenaz-2 inhibit�rleri olarak ikameli piridinler.
SE8600913L (sv) Kemiska foreningar
DE3372707D1 (en) Spiro-(4,(3+n))-2-aza-alkan-3-carboxylic-acid derivatives, process for their preparation,agents containing them and their use
NO913923L (no) 17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse
BG100692A (en) New heterocyclic compounds
HUP9902133A2 (hu) Mikroszomális trigliceridtranszfer-proteint gátló aromás inhibitorok
DE69709568T2 (de) Halo-substituierte Protein Kinase C Inhibitoren
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
ES512574A0 (es) "procedimiento de preparacion de derivados carboxilato".
DE69315836D1 (de) Pyrazolpyridine für die behandlung der anämie
TR200103561T2 (tr) Rodanin türevleri ve amiloidlerin önlenmesi ve görüntülenmesinde kullanımları
DK118390A (da) Substituerede quinoliner
ES8609322A1 (es) Un procedimiento de obtencion de imidazoquinolinas
DK449488A (da) Disubstituerede tetrazol-forbindelser med leukotrien-antagonistvirkning, fremgangsmaade til fremstil ling heraf og middel til brug ved fremgangsmaaden
RO82161A (fr) Procede pour preparer 2-(2-chlore-4-cyclopropylphenyleimino)-imidazolidine
DK0823254T3 (da) Hidtil ukendt anvendelse af pyrazolopyridinforbindelser
ES493044A0 (es) Un procedimiento para la preparacion de agentes antibacterianos beta-lactanicos.